These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34216699)

  • 21. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
    Carlquist JF; Muhlestein JB; Anderson JL
    Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
    Mannheim D; Herrmann J; Versari D; Gössl M; Meyer FB; McConnell JP; Lerman LO; Lerman A
    Stroke; 2008 May; 39(5):1448-55. PubMed ID: 18356547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized phospholipids and lipoprotein-associated phospholipase A
    Pantazi D; Tellis C; Tselepis AD
    Biofactors; 2022 Nov; 48(6):1257-1270. PubMed ID: 36192834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lp-PLA2: a new kid on the block.
    Zalewski A; Nelson JJ; Hegg L; Macphee C
    Clin Chem; 2006 Sep; 52(9):1645-50. PubMed ID: 16873290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipoprotein associated phospholipase A2].
    Rubinstein A; Izkhakov E
    Harefuah; 2011 Feb; 150(2):136-40, 205. PubMed ID: 22164942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro.
    Turunen P; Jalkanen J; Heikura T; Puhakka H; Karppi J; Nyyssönen K; Ylä-Herttuala S
    J Lipid Res; 2004 Sep; 45(9):1633-9. PubMed ID: 15231855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lp-PLA2 silencing protects against ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR signaling pathway in human THP1 macrophages.
    Zheng H; Cui D; Quan X; Yang W; Li Y; Zhang L; Liu E
    Biochem Biophys Res Commun; 2016 Sep; 477(4):1017-1023. PubMed ID: 27392709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
    Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
    Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ω3-polyunsaturated fatty acids suppress lipoprotein-associated phospholipase A2 expression in macrophages and animal models.
    Li Z; Ren W; Han X; Liu X; Wang G; Zhang M; Pang D; Ouyang H; Tang X
    Mol Nutr Food Res; 2015 Sep; 59(9):1771-9. PubMed ID: 26018800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial.
    O'Donoghue M; Morrow DA; Sabatine MS; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    Circulation; 2006 Apr; 113(14):1745-52. PubMed ID: 16537575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: A systematic review.
    Younus A; Humayun C; Ahmad R; Ogunmoroti O; Kandimalla Y; Aziz M; Malik R; Saand AR; Valdes C; Badlani R; Younus MA; Ali SS; Chen Y; Nasir K
    J Clin Lipidol; 2017; 11(2):328-337. PubMed ID: 28502488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lp-PLA2 and sPLA2: cardiovascular biomarkers].
    Ait-Oufella H; Mallat Z; Tedgui A
    Med Sci (Paris); 2014 May; 30(5):526-31. PubMed ID: 24939539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein-associated phospholipase A(2) and atherosclerosis.
    Wilensky RL; Macphee CH
    Curr Opin Lipidol; 2009 Oct; 20(5):415-20. PubMed ID: 19667981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.
    Virani SS; Nambi V
    Curr Atheroscler Rep; 2007 Aug; 9(2):97-103. PubMed ID: 17877917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.
    Wang WY; Li J; Yang D; Xu W; Zha RP; Wang YP
    Cardiovasc Res; 2010 Mar; 85(4):845-52. PubMed ID: 19910444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients.
    Ishihara M; Iwasaki T; Nagano M; Ishii J; Takano M; Kujiraoka T; Tsuji M; Hattori H; Emi M
    J Hum Genet; 2004; 49(6):302-307. PubMed ID: 15148590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
    Yang M; Chu EM; Caslake MJ; Edelstein C; Scanu AM; Hill JS
    Biochim Biophys Acta; 2010 Feb; 1801(2):176-82. PubMed ID: 19895904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased acetylation of H3K14 in the genomic regions that encode trained immunity enzymes in lysophosphatidylcholine-activated human aortic endothelial cells - Novel qualification markers for chronic disease risk factors and conditional DAMPs.
    Lu Y; Sun Y; Drummer C; Nanayakkara GK; Shao Y; Saaoud F; Johnson C; Zhang R; Yu D; Li X; Yang WY; Yu J; Jiang X; Choi ET; Wang H; Yang X
    Redox Biol; 2019 Jun; 24():101221. PubMed ID: 31153039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.
    MacPhee CH; Moores KE; Boyd HF; Dhanak D; Ife RJ; Leach CA; Leake DS; Milliner KJ; Patterson RA; Suckling KE; Tew DG; Hickey DM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):479-87. PubMed ID: 10024526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.